GME
68
-5
BAC
80
3
FE
50
2
GRMN
45
8
PH
64
2
WEC
45
2
PFG
55
2
ADI
73
2
MRK
66
3
FOXA
66
2
ROST
68
-3
TMO
62
2
KMI
63
10
LB
33
2
BWA
55
2
KO
46
2
IR
63
5
A
51
8
AMAT
54
2
CF
41
-7
GME
68
-5
BAC
80
3
FE
50
2
GRMN
45
8
PH
64
2
WEC
45
2
PFG
55
2
ADI
73
2
MRK
66
3
FOXA
66
2
ROST
68
-3
TMO
62
2
KMI
63
10
LB
33
2
BWA
55
2
KO
46
2
IR
63
5
A
51
8
AMAT
54
2
CF
41
-7
Financhill
Back

Matthews Japan Active ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
54

JPAN
Matthews Japan Active ETF

Last Price:
$35.93
Seasonality Move:
5.65%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.34
Seasonality Move:
-10.99%
Buy
54
Matthews Japan Active ETF (JPAN) is a Buy

Is Matthews Japan Active ETF a Buy, Sell or Hold?

  • The current Matthews Japan Active ETF [JPAN] share price is $35.86. The Score for JPAN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • JPAN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JPAN Stock Price Chart

What is Matthews Japan Active ETF's stock price today?

  • The Matthews Japan Active ETF share price today is $35.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JPAN is experiencing slight selling pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

JPAN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 37.28 Sell
Chaikin Money Flow: -126 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.19 - 37.71) Sell
Bollinger Bands (100): (35.56 - 37.46) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

JPAN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.81 Sell
20-day SMA: 37.09 Sell
50-day SMA: 37.11 Sell
200-day SMA: 34.48 Buy
8-day EMA: 36.48 Sell
20-day EMA: 36.9 Sell
50-day EMA: 36.9 Sell
200-day EMA: 34.92 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Matthews Japan Active ETF Earnings Growth & JPAN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Matthews Japan Active ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):